These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12418986)

  • 1. The relationship of contextual factors to women's perceptions of medical abortion.
    Harvey SM; Beckman LJ; Roberts Branch M
    Health Care Women Int; 2002; 23(6-7):654-65. PubMed ID: 12418986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and perceptions of medical abortion among potential users.
    Harvey SM; Beckman LJ; Castle MA; Coeytaux F
    Fam Plann Perspect; 1995; 27(5):203-7. PubMed ID: 9104607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics.
    Ganatra B; Kalyanwala S; Elul B; Coyaji K; Tewari S
    Glob Public Health; 2010; 5(4):335-47. PubMed ID: 19431005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortion.
    Fielding SL; Schaff EA
    Qual Health Res; 2004 May; 14(5):612-27. PubMed ID: 15107166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting abortion decisions among young couples in Nepal.
    Puri M; Ingham R; Matthews Z
    J Adolesc Health; 2007 Jun; 40(6):535-42. PubMed ID: 17531760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making unsafe abortion safe: medical method.
    Pradhan P
    Nepal Med Coll J; 2004 Dec; 6(2):147-51. PubMed ID: 16295750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listening and learning from women about mifepristone: implications for counseling and health education.
    Castle MA; Harvey SM; Beckman L; Coeytaux F; Garrity JM
    Womens Health Issues; 1995; 5(3):130-8. PubMed ID: 7549491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study supports the introduction of early medical abortion in Turkey.
    Akin A; Kocoglu GO; Akin L
    Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of telephone follow-up after medical abortion.
    Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
    Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study.
    Hajri S; Blum J; Gueddana N; Saadi H; Maazoun L; Chélli H; Dabash R; Winikoff B
    Contraception; 2004 Dec; 70(6):487-91. PubMed ID: 15541411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abortion in Canada: religious and ideological dimensions of women's attitudes.
    Krishnan V
    Soc Biol; 1991; 38(3-4):249-57. PubMed ID: 1801205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of mifepristone.
    Tang OS; Ho PC
    Gynecol Endocrinol; 2006 Dec; 22(12):655-9. PubMed ID: 17162706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological outcomes of medical versus surgical elective first trimester abortion.
    Crandell L
    Nurs Womens Health; 2012; 16(4):296-307. PubMed ID: 22900806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.